Evidence map›Paper›PMID 39754456›Full record

Trial reportTherapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy2026

Evaluation of the effect of therapeutic plasma exchange on serum cytokine levels in pediatric intensive care unit.

Selen Ceren Cakmak, Hazal Ceren Tugrul, Dilan Akgun Unlu, Rasit Alkan Albayrak, Gurkan Atay, Seher Erdogan, Betul Sozeri

Abstract readClinical Trial
In one paragraph

Trial report in Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Selen Ceren CakmakDepartment of Pediatrics, Health Science University, Umraniye Research and Training Hospital, Istanbul, Turkey.ORCID https://orcid.org/0000-0003-1485-3664
Hazal Ceren TugrulDepartment of Pediatric Critical Care, Health Science University, Umraniye Research and Training Hospital, Istanbul, Turkey.ORCID https://orcid.org/0000-0003-4990-0408
Dilan Akgun UnluDepartment of Pediatrics, Health Science University, Umraniye Research and Training Hospital, Istanbul, Turkey.ORCID https://orcid.org/0009-0009-9791-5664
Rasit Alkan AlbayrakDepartment of Pediatrics, Health Science University, Umraniye Research and Training Hospital, Istanbul, Turkey.ORCID https://orcid.org/0009-0006-0738-2517
Gurkan AtayDepartment of Pediatric Critical Care, Health Science University, Umraniye Research and Training Hospital, Istanbul, Turkey.ORCID https://orcid.org/0000-0002-0317-5872
Seher ErdoganDepartment of Pediatric Critical Care, Health Science University, Umraniye Research and Training Hospital, Istanbul, Turkey.ORCID https://orcid.org/0000-0002-3393-3363
Betul SozeriDepartment of Pediatric Rheumatology, Health Science University, Umraniye Research and Training Hospital, Istanbul, Turkey.ORCID https://orcid.org/0000-0003-0358-6409

Funding

Scientific Research Projects Coordinatorship
6 · The paper itself

Abstract

introductionTherapeutic plasma exchange (TPE) is crucial for saving lives when used appropriately. This study aimed to assess TPE's impact on tumor necrosis factor-like weak inducer of apoptosis (TWEAK) protein and IL-6 levels in critically ill pediatric patients.

methodsConducted between May 2022 and December 2022, the study observed pediatric intensive care unit (PICU) patients undergoing TPE, recording demographics, lab results, TWEAK, and IL-6 levels pre- and post-procedure.

resultsOf 41 patients, 53.7% were male, 51.2% had underlying conditions, and 39% showed sepsis symptoms. IL-6 levels significantly rose post-TPE (p: 0.006), while TWEAK protein levels dropped (p: 0.030). Positive correlations were found between interleukin-6 (IL-6) pre-TPE and ventilation duration, ferritin levels (p <0.05), and TWEAK pre-TPE and organ failure indicators, D-Dimer levels (p <0.05). Prognosis showed no significant difference in IL-6/TWEAK levels (p >0.05).

conclusionSerum IL-6 and TWEAK can indicate disease severity and inflammation level, but may not predict prognosis accurately. CLINICAL

trial registrationOur study has clinical study registration number B.10.1.TKH.4.34.H.GP.0.01/154 of the University of Health Sciences Ümraniye Training and Research Hospital.

Indexed as

CytokinesCytokine TWEAKInterleukin-6Plasma ExchangeChildChild, PreschoolCritical IllnessFemaleHumansInfantIntensive Care Units, PediatricMalePrognosisCytokinesCytokine TWEAKInterleukin-6TNFSF12 protein, humanIL‐6pediatric intensive care unittherapeutic plasma exchangeTWEAK

Identifiers

PMID39754456
PMCPMC13540556

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.